Examinant per Autoria "Reck, Martin"
Mostrant 1 - 3 de 3
Resultats per pàgina
Opcions d'ordenació
Ítem Accés Obert An open-label, multicenter, randomized, phase II study of Cisplatin and Pemetrexed with or without Cixutumumab (IMC-A12) as a first-line therapy in patients with advanced nonsquamous non-small cell lung cancer.(Elsevier, 2017) Novello, Silvia; Scagliotti, Giorgio; De Castro, Gilberto; Kiyik, Murat; Kowalyszyn, Rubén; Deppermann, Karl-Matthias; Arriola Aperribay, Edurne; Bosquee, Lionel; Novosiadly, Ruslan D.; Nguyen, Tuan S.; Forest, Amelie; Tang, Shande; Kambhampati, Siva Rama Prasad; Cosaert, Jan; Reck, Martin
Ítem Accés Obert Comparison of plasma ctDNA and tissue/cytology-based techniques for the detection of EGFR mutation status in advanced NSCLC: Spanish data subset from ASSESS(SpringerOpen, 2018) Arriola Aperribay, Edurne; Paredes, Alfredo; García Gomez, R.; Diz Tain, Pilar; Constenla, M.; García Girón, C.; Márquez, G.; Reck, Martin; López Vivanco, G.
Ítem Accés Obert ctDNA Determination of EGFR Mutation Status in European and Japanese Patients with Advanced NSCLC: The ASSESS Study.(Elsevier, 2006) Reck, Martin; Hagiwara, Koichi; Han, Baohui; Tjulandin, Sergei; Grohé, Christian; Yokoi, Takashi; Morabito, Alessandro; Novello, Silvia; Arriola Aperribay, Edurne; Molinier, Olivier; McCormack, Rose; Ratcliffe, Marianne; Normanno, Nicola